Vesuvius Pharmaceuticals, Inc. — Form D
Vesuvius Pharmaceuticals, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2015-01-05. The offering totals $33.0M, of which $10.2M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2015-01-05
- Form: D
- Accession: 0001629592-15-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $33.0M
- Amount sold: $10.2M
- Remaining: $22.8M
- Investors: 5
- Date of first sale: 2014-12-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-231374
Issuer
- Name: Vesuvius Pharmaceuticals, Inc.
- CIK: 0001629592
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: C/O MPM CAPITAL, BOSTON, MA, 02116
- Phone: 617-425-9215
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Luke Evnin | Director | Watertown, MA |
| Phil Gutry | Director | Baltimore, MD |
| Daniel Hicklin | Director | Cambridge, MA |
| Arnold Oronsky | Director | BOSTON, MA |
| David Cordo | Executive Officer | Cambridge, MA |
| Daniel Hicklin | Executive Officer | Cambridge, MA |
More